Steven Cohen Albireo Pharma, Inc. Transaction History

Point72 Asset Management, L.P.

$36.6 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$0.0 - $44.95 $0 - $1.09 Million	-24,200 Closed	0 $0
Q4 2022 Feb 14, 2023	SELL	$18.01 - $23.78 $970,739 - $1.28 Million	-53,900 Reduced 69.01%	24,200 $522,000
Q3 2022 Nov 14, 2022	BUY	$16.32 - $26.37 $1.27 Million - $2.06 Million	78,100 New	78,100 $1.51 Million
Q2 2022 Aug 15, 2022	SELL	$18.54 - $37.29 $3.14 Million - $6.32 Million	-169,600 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$23.94 - $33.74 $2.89 Million - $4.07 Million	120,710 Added 246.9%	169,600 $5.06 Million
Q4 2021 Feb 14, 2022	BUY	$21.19 - $31.29 $1.04 Million - $1.53 Million	48,890 New	48,890 $1.14 Million
Q3 2020 Nov 16, 2020	SELL	$23.19 - $41.61 $4.06 Million - $7.28 Million	-175,000 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$14.82 - $29.92 $5.04 Million - $10.2 Million	-340,000 Reduced 66.02%	175,000 $4.64 Million
Q1 2020 May 15, 2020	BUY	$11.67 - $27.23 $3.54 Million - $8.25 Million	302,970 Added 142.89%	515,000 $8.43 Million
Q4 2019 Feb 14, 2020	BUY	$16.92 - $28.96 $2.1 Million - $3.59 Million	124,124 Added 141.2%	212,030 $5.39 Million
Q3 2019 Nov 15, 2019	SELL	$20.0 - $31.88 $1.58 Million - $2.52 Million	-79,058 Reduced 47.35%	87,906 $1.76 Million
Q2 2019 Aug 14, 2019	SELL	$30.67 - $37.86 $507,005 - $625,863	-16,531 Reduced 9.01%	166,964 $5.38 Million
Q1 2019 May 15, 2019	BUY	$22.22 - $32.21 $3.77 Million - $5.47 Million	169,795 Added 1239.38%	183,495 $5.91 Million
Q4 2018 Feb 14, 2019	BUY	$20.9 - $32.57 $286,330 - $446,209	13,700 New	13,700 $336,000
Q4 2017 Feb 14, 2018	SELL	$21.56 - $28.14 $4.02 Million - $5.25 Million	-186,640 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$20.44 - $25.65 $3.81 Million - $4.79 Million	186,640	186,640 $3.91 Million

Others Institutions Holding ALBO

# of Institutions

Shares Held

865

Call Options Held

Put Options Held

View Full List

About ALBIREO PHARMA, INC.

Ticker ALBO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 19,612,500
Description
Albireo Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel bile acid modulators to treat orphan pediatric liver diseases and other liver or gastrointestinal diseases and disorders. The company offers Bylvay for the treatment of progressive familial intrahepatic cholestasis, as we...

More about ALBO

Track Steven Cohen's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.

Account